What is in our complete Cardiometabolic Risk Assessment Report

Our comprehensive and actionable Cardiometabolic Risk Assessment gives you and your patient a clear assessment of their individual Metabolic Severity Score, risk of developing type 2 diabetes, and cardiovascular risk scores.

Part 1: A graphical summary of the patient’s overall Cardiometabolic Risk scores

• Focuses attention on the modifiable metabolic factors that constitute Insulin Resistance Syndrome (“Metabolic Syndrome”)

• Provides easy-to-follow graphics that identify the severity of the patient’s Metabolic Risk, Diabetic Risk, and Cardiovascular Risk

• Serves as a quick reference during your next clinical or tele-health encounter

Although this summary alone may be enough, we unpack the details in the following sections of the report to provide additional context to the individualized risk values shown here.

Part 2: Metabolic Syndrome Risk Summary

• Identifies the patient’s insulin resistance status using LabCorp’s NMR Lipoprotein Insulin Resistance (LP-IR) Score

• Outlines patient-specific values that constitute Metabolic Syndrome

• Reports high-risk inflammatory and lipoprotein particle number values that increase insulin resistance related to greater diabetic and cardiovascular risk

• Incorporates an outcome-proven Metabolic Syndrome Severity Score that further discriminants individual risk beyond individual metabolic syndrome factors

Part 3: Diabetic Risk Score Summary

• Graphically presents the patient’s current fasting glucose and NMR Lipoprotein Insulin Resistance (LP-IR) Score

• Reports the patient’s gender-specific 8-Year Risk of Developing Diabetes based on outcome data integrating fasting glucose and LP-IR values

• Demonstrates that the patient’s personal diabetic risk is modifiable through improvement in their LP-IR Score and fasting glucose values

Part 4: Cardiovascular Risk Summary

• Reports the patient’s 10-year and lifetime cardiovascular risk score based on the American College of Cardiology (ACC) guidelines

• Identifies any of the 24 individual risk enhancing factors that contribute to a patient’s cardiovascular risk

• Determines a patient’s Overall Cardiovascular Risk by incorporating their calculated risk and presence of risk enhancing factors

• Uses national and international guidelines to provide patient-specific lipoprotein management goals

This section in specifically tuned to provide patients a comprehensive understanding of their risk and goals that, when met, will optimize cardiovascular risk reduction.

Part 5: Longitudinal tracking of risk scores and biomarkers over time

• Clearly demonstrates the impact of clinical and behavioral interventions over time

• The design visually reinforces improved behavior toward a healthier risk score

• Cumulative tracking pages are a working document to set goals for future clinical encounters 

Our data  shows that seeing biomarker response over time has a positive association with maintaining goal values. Positive feedback drives continued behavior improvements that you and your patient can both see.

Part 6: LabCorp’s complete Nuclear Magnetic Resonance (NMR) LipoProfile® report and additional relevant biomarker values

• Important lipoprotein values: LDL particle number (ApoB or LDL-P) as well as traditional cholesterol and triglyceride values (total cholesterol, triglycerides, HDL & LDL)

• Fasting glucose & Lipoprotein Insulin Resistance (LP-IR) Score

• Hemoglobin A1C

• Lipoprotein (a)

• GlycA (NMR biomarker of systemic inflammation)

Although our report wraps significant context around the point-in-time biomarkers from LabCorp’s NMR LipoProfile® report, we know seeing the raw values is important, too.